https://www.selleckchem.com/pr....oducts/ecc5004-azd50
clinical factor, further targets for improved COPD therapies during the clinically stable state may be elucidated. Pain is reported as the leading cause of disability in the common forms of inflammatory arthritis conditions. Acting as a key player in nociceptive processing, neuroinflammation, and neuron-glia communication, the chemokine CCL2/CCR2 axis holds great promise for controlling chronic painful arthritis. Here, we investigated how the CCL2/CCR2 system in the dorsal root ganglion (DRG) contributes to the peripheral inflam
Like
Comment
Share
